## Management of Recurrent Antepartum Hemorrhage in Placenta Previa at 34 Weeks ### Clinical Scenario Analysis This patient presents with: - **Gestational age:** 34 weeks (preterm — below the 36–37 week threshold for elective delivery in stable placenta previa) - **Bleeding pattern:** Recurrent (third episode in 3 weeks), but currently hemodynamically **stable** - **Hemodynamic status:** Stable - **Placental type:** Partial previa - **Fetal status:** Reassuring ### Rationale for Expectant Management with Corticosteroids **Key Point:** In a hemodynamically stable patient with placenta previa at 34 weeks, the standard of care is **expectant (conservative) inpatient management** with corticosteroids for fetal lung maturity, targeting delivery at **36–37 weeks**. Immediate delivery at 34 weeks is NOT indicated unless there is hemodynamic instability, uncontrolled hemorrhage, or fetal compromise. **High-Yield (ACOG / Williams Obstetrics):** The threshold for delivery in placenta previa: - **< 36 weeks, hemodynamically stable (even with recurrent bleeding):** Expectant management in hospital + corticosteroids; plan delivery at 36–37 weeks - **Hemodynamic instability OR uncontrolled hemorrhage OR fetal compromise at any GA:** Emergency cesarean section - **≥ 36–37 weeks:** Elective cesarean section ### Why Delivery at 34 Weeks Is Premature Proceeding to cesarean section at 34 weeks in a **stable** patient with a **reassuring fetal heart rate** exposes the neonate to significant late-preterm morbidity (respiratory distress syndrome, feeding difficulties, prolonged NICU stay) without a compelling maternal or fetal indication. The current episode of bleeding has been managed and the patient is stable — this does not constitute an emergency. **Clinical Pearl (Williams Obstetrics, 25th ed.):** Recurrent bleeding episodes in placenta previa, while increasing vigilance, do not by themselves mandate delivery before 36 weeks if the patient remains hemodynamically stable and the fetus is not compromised. Corticosteroids should be administered to accelerate fetal lung maturity, and delivery planned at 36 weeks. ### Decision Pathway | Scenario | Management | |---|---| | Stable, < 36 weeks, any bleeding pattern | Expectant (inpatient) + corticosteroids; plan LSCS at 36–37 weeks | | Unstable / massive hemorrhage / fetal distress | Emergency LSCS regardless of GA | | Stable, ≥ 36–37 weeks | Elective LSCS | ### Management Steps at 34 Weeks with Recurrent Bleeding (Stable) 1. **Admit to hospital** — inpatient monitoring is mandatory; home management (Option B) is inappropriate for recurrent APH 2. **Corticosteroids:** Administer betamethasone 12 mg IM × 2 doses 24 h apart (or a single rescue dose if prior course > 2 weeks ago) to promote fetal lung maturity 3. **Plan delivery at 36 weeks** by elective cesarean section 4. **Supportive care:** IV access, cross-match blood, hemoglobin monitoring, fetal surveillance 5. **Avoid digital vaginal examination** — contraindicated in confirmed placenta previa ### Why Other Options Are Incorrect - **Option B (Home management):** Inappropriate — recurrent APH requires inpatient monitoring with transfusion standby - **Option C (Double setup examination):** Contraindicated when placenta previa is already confirmed on ultrasound; adds no diagnostic value and risks catastrophic hemorrhage - **Option D (Betamethasone + LSCS at 34 weeks):** Premature delivery in a stable patient; neonatal morbidity at 34 weeks is significant and avoidable by waiting until 36 weeks **High-Yield:** Corticosteroids + expectant management targeting 36–37 weeks is the cornerstone of management for stable placenta previa with recurrent bleeding before 36 weeks (ACOG Practice Bulletin No. 214; Williams Obstetrics, 25th ed.).
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.